CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Rigel Pharmaceuticals announced inducement grants under NASDAQ Listing Rule 5635(c)(4), approved by the Compensation Committee of its Board of Directors.

Importance:2/10
Sentiment:
0.00
equity compensationinducement grantsNASDAQ Listing Rule 5635
Related Companies

Read the original article

Published by PR Newswire Biotech on October 2, 2026 12:05 PM

Read Original